These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
473 related items for PubMed ID: 16872514
1. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J, Frisch M. Arthritis Res Ther; 2006; 8(4):R133. PubMed ID: 16872514 [Abstract] [Full Text] [Related]
2. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, Pedersen BV, Wohlfahrt J, Frisch M. Arthritis Rheum; 2007 May; 56(5):1446-53. PubMed ID: 17469102 [Abstract] [Full Text] [Related]
3. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC. Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396 [Abstract] [Full Text] [Related]
4. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Huizinga TW, de Vries RR, Toes RE. Arthritis Rheum; 2005 Oct; 52(10):3058-62. PubMed ID: 16200610 [Abstract] [Full Text] [Related]
6. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. López-Longo FJ, Oliver-Miñarro D, de la Torre I, González-Díaz de Rábago E, Sánchez-Ramón S, Rodríguez-Mahou M, Paravisini A, Monteagudo I, González CM, García-Castro M, Casas MD, Carreño L. Arthritis Rheum; 2009 Apr 15; 61(4):419-24. PubMed ID: 19333979 [Abstract] [Full Text] [Related]
7. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, Lum RF, de Vries RR, Gregersen PK, Toes RE, Criswell LA. Arthritis Rheum; 2005 Nov 15; 52(11):3433-8. PubMed ID: 16255021 [Abstract] [Full Text] [Related]
9. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis]. Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M. Mikrobiyol Bul; 2008 Oct 15; 42(4):669-74. PubMed ID: 19149089 [Abstract] [Full Text] [Related]
10. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Lee HS, Irigoyen P, Kern M, Lee A, Batliwalla F, Khalili H, Wolfe F, Lum RF, Massarotti E, Weisman M, Bombardier C, Karlson EW, Criswell LA, Vlietinck R, Gregersen PK. Arthritis Rheum; 2007 Jun 15; 56(6):1745-53. PubMed ID: 17530703 [Abstract] [Full Text] [Related]
11. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test? Panchagnula R, Rajiv SR, Prakash J, Chandrashekara S, Suresh KP. J Clin Rheumatol; 2006 Aug 15; 12(4):172-5. PubMed ID: 16891919 [Abstract] [Full Text] [Related]
12. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis. Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ. Scand J Rheumatol; 2008 Aug 15; 37(3):183-7. PubMed ID: 18465452 [Abstract] [Full Text] [Related]
13. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieudé P, Prum B, Cornélis F, Petit-Teixeira E. Ann Rheum Dis; 2008 Apr 15; 67(4):466-70. PubMed ID: 17660221 [Abstract] [Full Text] [Related]
14. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1]. Correa PA, Tobón GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM. Biomedica; 2004 Jun 15; 24(2):140-52. PubMed ID: 15495594 [Abstract] [Full Text] [Related]
16. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles. Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van Mil AH, Jol-van der Zijde CM, van Tol MJ, Drijfhout JW, Breedveld FC, de Vries RR, Huizinga TW, Toes RE. Arthritis Rheum; 2007 Sep 15; 56(9):2913-8. PubMed ID: 17763436 [Abstract] [Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. Kim SK, Park SH, Shin IH, Choe JY. J Rheumatol; 2008 Jun 15; 35(6):995-1001. PubMed ID: 18464311 [Abstract] [Full Text] [Related]
19. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S. Arthritis Res Ther; 2007 Jun 15; 9(3):R56. PubMed ID: 17553139 [Abstract] [Full Text] [Related]
20. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis. Kapitány A, Szabó Z, Lakos G, Aleksza M, Végvári A, Soós L, Karányi Z, Sipka S, Szegedi G, Szekanecz Z. Isr Med Assoc J; 2008 Jan 15; 10(1):32-6. PubMed ID: 18300568 [Abstract] [Full Text] [Related] Page: [Next] [New Search]